Work

The mTOR Inhibitor RAD001 (Everolimus) Inhibits Myeloma Tumor Growth In Vivo and Enhances the Anti-MM Effects of Bortezomib and Arsenic Trioxide.

Year: 2007

Type: article

Source: Blood

DOI: 10.1182/blood.v110.11.4801.4801

Authors: Richard A. Campbell, Eric Sanchez, Jeffrey Steinberg, Michael Share, Joseph Wang, Mingjie Li, Richard Leuchter, Haiming Chen, Dror Shalitin, Shen Pang, Jonathan Said, James R. Berenson

Institutions: Institute for Myeloma & Bone Cancer Research, University of California, Los Angeles

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2582705076

FWCI: 0.378

Cites:

Cited by: 3

Related to: 10